ARCHIVES

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 8 | August 27, 2010

Download PDF Visit The Full Archive

Related Articles

Study Links Native American Ancestry to Leukemia Relapse

February 25, 2011

FDA Proposes To Require Electronic Submission

May 3, 2002

Changes Put Pharma In Control Of Trials Traditionally Conducted By Academics.

March 26, 2010

NCI Boosts Funding For Cooperative Groups by $25 Million, Cuts Overall Accrual by 20 Percent, to 20,000 Patients

November 11, 2011

RFA Available

January 15, 1999

Group Lobby To Add $200 Mil. To Cancer Budget

April 26, 1991